News | July 29, 2009

Calypso Touts Deal to Develop RT Cancer Treatment with Varian

July 29, 2009 – At the AAPM 51st Annual Meeting, Calypso Medical Technologies touted its strategic development agreement with Varian Medical Systems to jointly develop products integrating its Calypso System with Varian’s radiotherapy treatment technologies.

Calypso Medical’s proprietary technology utilizes miniature implanted transponders to provide precise, continuous, real-time information about the location of the tumor target during external beam radiation therapy. Calypso’s technology provides continuous tumor position information designed to enable the correct radiation dose to be delivered to the tumor while minimizing the amount of radiation misapplied to normal tissue.

The Calypso technology is complementary to Varian’s state-of-the-art technology for delivering intensity-modulated radiotherapy (IMRT), including RapidArc radiotherapy. Varian is the market share leader for linear accelerators worldwide.

“This strategic development agreement will facilitate advanced treatment capabilities through the integration of the Calypso System with Varian’s market-leading radiotherapy technologies,” said Eric R. Meier, president and chief executive officer of Calypso Medical. “We believe these efforts may prove beneficial for prostate patients as well as some of the more difficult radiation therapy targets such as pancreas and lung. In the near term, two exciting joint development efforts will integrate the motion management capabilities of our Calypso System with Varian’s state-of-the-art treatment platform. This agreement will provide the framework for the joint development of Real-Time MLC Tracking, a future capability* demonstrated by both companies last year, which causes the radiation beam to move in concert with the tumor target based on real-time tracking data provided by the Calypso System.”

Under the terms of the agreement, the two companies will jointly develop products that integrate the Calypso System with Varian’s technologies. Further terms of the agreement were not disclosed.

* This technology is a concept device under development and not available for sale.

For more information: www.calypsomedical.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init